NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/20/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization921.34 mln
Float18.83 mln
Earnings Date08/17/2026
Piotroski F-Score
2
/ 9
Weak
1-Year Forecast
64.75
Strong upside
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-117
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Forte Biosciences is a US-based medical research company focused on developing new treatments for autoimmune conditions. Its main drug candidate, FB-102, is a specially designed antibody that targets specific immune system pathways and is being studied as a potential treatment for conditions such as graft-versus-host disease, vitiligo, alopecia areata, and celiac disease. The company is based in Dallas, Texas.
